Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,359 public trials 538 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

NCT05826535

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • University of California-Irvine Medical Center Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Scripps Clinic San Diego, California, United States
View all 35 locations
View Trial Details
Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06769698

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
View all 35 locations
View Trial Details
Recruiting

A Study of CTD402 in T-ALL/LBL Patients

NCT07070219

Conditions
Acute Lymphocytic Leukemia Refractory, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

NCT05714839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site Bullhead City, Arizona, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
View all 44 locations
View Trial Details
Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT06292780

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute/SCRI Denver, Colorado, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 21 locations
View Trial Details
Recruiting

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

NCT06993506

Conditions
Disease Attributes, HER2-negative Breast Cancer, Metastasis, +6 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
View all 19 locations
View Trial Details

Related conditions